Literature DB >> 27574552

Road map for pain management in pancreatic cancer: A review.

Marie José Lahoud1, Hampig Raphael Kourie1, Joelle Antoun1, Lana El Osta1, Marwan Ghosn1.   

Abstract

Beside its poor prognosis and its late diagnosis, pancreatic cancer remains one of the most painful malignancies. Optimal management of pain in this cancer represents a real challenge for the oncologist whose objective is to ensure a better quality of life to his patients. We aimed in this paper to review all the treatment modalities incriminated in the management of pain in pancreatic cancer going from painkillers, chemotherapy, radiation therapy and interventional techniques to agents under investigation and alternative medicine. Although specific guidelines and recommendations for pain management in pancreatic cancer are still absent, we present all the possible pain treatments, with a progression from medical multimodal treatment to radiotherapy and chemotherapy then interventional techniques in case of resistance. In addition, alternative methods such as acupuncture and hypnosis can be added at any stage and seems to contribute to pain relief.

Entities:  

Keywords:  Interventional; Medical; Pain management; Pancreatic cancer; Treatment

Year:  2016        PMID: 27574552      PMCID: PMC4980650          DOI: 10.4251/wjgo.v8.i8.599

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  75 in total

1.  EUS-guided celiac block and neurolysis.

Authors:  D Collins; I Penman; G Mishra; P Draganov
Journal:  Endoscopy       Date:  2006-09       Impact factor: 10.093

Review 2.  Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature.

Authors:  Quy N H Tran; Shiro Urayama; Frederick J Meyers
Journal:  J Support Oncol       Date:  2006-10

3.  Neural invasion in pancreatic cancer: a mutual tropism between neurons and cancer cells.

Authors:  Güralp O Ceyhan; Ihsan Ekin Demir; Burak Altintas; Ulrich Rauch; Gerald Thiel; Michael W Müller; Nathalia A Giese; Helmut Friess; Karl-Herbert Schäfer
Journal:  Biochem Biophys Res Commun       Date:  2008-07-18       Impact factor: 3.575

4.  Efficacy and tolerability of intranasal fentanyl spray in cancer patients with breakthrough pain.

Authors:  Morten Thronæs; Lars Popper; Martin Eeg; Ellen Jaatun; Magnar Kvitberg; Stein Kaasa
Journal:  Clin Ther       Date:  2015-01-30       Impact factor: 3.393

Review 5.  Opioids and cancer recurrence.

Authors:  Rohit Juneja
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

6.  Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain.

Authors:  A Caraceni; E Zecca; C Martini; F De Conno
Journal:  J Pain Symptom Manage       Date:  1999-06       Impact factor: 3.612

7.  Nerve growth factor and its high-affinity receptor in chronic pancreatitis.

Authors:  H Friess; Z W Zhu; F F di Mola; C Kulli; H U Graber; A Andren-Sandberg; A Zimmermann; M Korc; M Reinshagen; M W Büchler
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

8.  A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.

Authors:  Camilla Staahl; Lona Louring Christrup; Søren Due Andersen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Pain       Date:  2006-04-04       Impact factor: 6.961

9.  Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage.

Authors:  D E Bockman; M Büchler; H G Beger
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

10.  How to improve the efficacy of endoscopic ultrasound-guided celiac plexus neurolysis in pain management in patients with pancreatic cancer: analysis in a single center.

Authors:  Hao Si-Jie; Xu Wei-Jia; Di Yang; Yao Lie; Yang Feng; Jiang Yong-Jian; Li Ji; Jin Chen; Zhong Liang; Fu De-Liang
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2014-02       Impact factor: 1.719

View more
  10 in total

1.  Novel role of the Mu-opioid receptor in pancreatic cancer: potential link between opioid use and cancer progression.

Authors:  Muhammad R Haque; Usman Barlass; Andrew Armstrong; Maliha Shaikh; Faraz Bishehsari
Journal:  Mol Cell Biochem       Date:  2022-02-09       Impact factor: 3.396

2.  Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac Plexus Neurolysis.

Authors:  Savas Comlek
Journal:  J Pain Res       Date:  2020-08-12       Impact factor: 3.133

Review 3.  Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review.

Authors:  William Paul Skelton; Hiral Parekh; Jason S Starr; Jose Trevino; Jessica Cioffi; Steven Hughes; Thomas J George
Journal:  J Gastrointest Cancer       Date:  2018-03

Review 4.  Pancreas Cancer-Associated Pain Management.

Authors:  Andrew L Coveler; Jonathan Mizrahi; Bory Eastman; Smith Jim Apisarnthanarax; Shalini Dalal; Terry McNearney; Shubham Pant
Journal:  Oncologist       Date:  2021-05-12

Review 5.  An update on treatment options for pancreatic adenocarcinoma.

Authors:  Aurélien Lambert; Lilian Schwarz; Ivan Borbath; Aline Henry; Jean-Luc Van Laethem; David Malka; Michel Ducreux; Thierry Conroy
Journal:  Ther Adv Med Oncol       Date:  2019-09-25       Impact factor: 8.168

6.  Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.

Authors:  P Hammel; H L Kindler; M Reni; E Van Cutsem; T Macarulla; M J Hall; J O Park; D Hochhauser; D Arnold; D-Y Oh; A Reinacher-Schick; G Tortora; H Algül; E M O'Reilly; D McGuinness; K Y Cui; S Joo; H K Yoo; N Patel; T Golan
Journal:  Ann Oncol       Date:  2019-12-01       Impact factor: 32.976

7.  Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.

Authors:  Usman Barlass; Ameya Deshmukh; Todd Beck; Faraz Bishehsari
Journal:  PLoS One       Date:  2021-01-06       Impact factor: 3.240

8.  Use of symptom-focused oncological cancer therapies in hospices: a retrospective analysis.

Authors:  Ulrich Kaiser; Ursula Vehling-Kaiser; Fabian Kück; Nicolae-Catalin Mechie; Ana Hoffmann; Florian Kaiser
Journal:  BMC Palliat Care       Date:  2020-09-12       Impact factor: 3.234

9.  The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision.

Authors:  Biaoxiang Xu; Yuan Zhou; Qian Pei; Fengbo Tan; Lilan Zhao; Cenap Güngör; Dan Wang; Yuqiang Li; Wenxue Liu; Zhongyi Zhou
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

10.  Coeliac plexus radiosurgery for pain management in patients with advanced cancer : study protocol for a phase II clinical trial.

Authors:  Galia Jacobson; Ronen Fluss; Amira Dany-BenShushan; Talia Golan; Tikva Meron; Camilla Zimmermann; Laura A Dawson; Aisling Barry; Marcin Miszczyk; Michael Buckstein; Dayssy Diaz Pardo; Artur Aguiar; Liat Hammer; Adam P Dicker; Maoz Ben-Ailan; Ofir Morag; David Hausner; Zvi Symon; Yaacov R Lawrence
Journal:  BMJ Open       Date:  2022-03-24       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.